共 40 条
- [1] NEONATAL TREATMENT OF WISTAR RATS WITH THE VASOPRESSIN ANTAGONIST DP[TYR(ME)2]AVP INHIBITS POSTNATAL BODY AND BRAIN-DEVELOPMENT AND INDUCES DIABETES-INSIPIDUS [J]. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1987, 26 (02): : 200 - 201
- [3] PHARMACOLOGICAL EVALUATION OF D(CH2)5TYR(ME)AVP AS AN ANTAGONIST OF VASOPRESSIN-INDUCED CONTRACTION OF THE ISOLATED RAT CAUDAL ARTERY [J]. ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1986, 284 (01): : 72 - 84
- [4] RENAL MEDULLARY BLOOD-FLOW - EFFECT OF VASOPRESSIN (AVP) AND THE VASCULAR ANTAGONIST D(CH2)5TYR (ME)AVP - VIDEOMICROSCOPIC STUDY IN RATS [J]. RENAL PHYSIOLOGY AND BIOCHEMISTRY, 1986, 9 (1-2): : 87 - 88
- [9] PREVENTION OF RENAL CORTICAL NECROSIS BY THE VASOPRESSIN ANTAGONIST D/CH2/5TYR/MET/AVP IN RATS TREATED WITH ESTRONE PLUS VASOPRESSIN [J]. ACTA ENDOCRINOLOGICA, 1985, 109 : 114 - 114
- [10] DESENSITIZATION OF RENAL VASOPRESSIN RECEPTOR AND VASOPRESSIN STIMULATED ADENYLATE-CYCLASE FOLLOWING DDAVP ADMINISTRATION INVIVO - PARTIAL PREVENTION OF DESENSITIZATION BY A VASOPRESSIN ANTAGONIST, D(CH2)5TYR(ME)AVP [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 1987, 43 : P184 - P184